• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

AMS to show Aurora with FDA clearance

Article

Advanced Mammography Systems will enjoy its first RSNA meetingwith 510(k) clearance for its Aurora 0.5-tesla dedicated MR mammographyscanner, which it is marketing at a list price of about $500,000.AMS, of Wilmington, MA, received the Food and Drug

Advanced Mammography Systems will enjoy its first RSNA meetingwith 510(k) clearance for its Aurora 0.5-tesla dedicated MR mammographyscanner, which it is marketing at a list price of about $500,000.AMS, of Wilmington, MA, received the Food and Drug Administration'simprimatur in February, and the first beta unit was installedat the Breast Imaging Center at the University of Texas MedicalBranch in Galveston. That center has examined over 200 women withthe system, AMS reported last month.

Aurora is an important part of a new corporate strategy adoptedearlier this year by AMS parent Advanced NMR Systems, which wasforced to shut down its InstaScan echo-planar imaging effort dueto slow sales (SCAN 6/19/96). Advanced NMR intends to open a networkof Aurora Breast Imaging centers to offer MR mammography services.The first such center will be installed in early 1997 at the Faulkner-SagoffCentre for Breast Health Care at Faulkner Hospital in Boston.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.